- Conditions: Cardiac Disease; Coronary Artery Disease
Intervention: Device: CELT ACD
Sponsors: Vasorum Ltd; Vasorum Ltd
Not yet recruiting - verified May 2012 - Condition: Hemophilia A
Interventions: Biological: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method; Biological: PEGylated Recombinant Factor VIII
Sponsors: Baxter Healthcare Corporation; Baxter Healthcare Corporation; Baxter Innovations GmbH
Recruiting - verified May 2012 - Conditions: cUTI; Complicated Urinary Tract Infection; Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - A Study to Compare LY2963016 to Lantus After a Single Dose to Subjects With Type 1 Diabetes MellitusCondition: Diabetes Mellitus, Type 1
Interventions: Drug: LY2963016; Drug: Lantus
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Not yet recruiting - verified May 2012 - Condition: Actinic Keratosis
Interventions: Drug: Ingenol mebutate gel, 0.015%; Drug: Vehicle gel
Sponsors: LEO Pharma; LEO Pharma
Recruiting - verified May 2012 - Conditions: Type 2 Diabetes Mellitus; Diabetic Foot Syndrome; Critical Limb Ischemia
Intervention:
Sponsors: GWT-TUD GmbH; GWT-TUD GmbH
Recruiting - verified May 2012 - Conditions: Surgery; Anaesthesia; Ventilator-Induced Lung Injury; Lung Injury; Pneumonia; Pneumothorax; Respiratory Distress Syndrome, Adult; Respiratory Insufficiency
Intervention:
Sponsors: European Society of Anaesthesiology; European Society of Anaesthesiology; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not yet recruiting - verified May 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 2; Healthy
Interventions: Drug: NNC 0148-0000-0362; Drug: insulin glargine; Drug: placebo; Drug: NNC 0148-0000-0362; Drug: NNC 0148-0000-0362; Drug: NNC 0148-0000-0362
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified May 2012 - Condition: Knee Osteoarthritis
Interventions: Drug: SAR113945; Drug: placebo
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Ovarian Cancer
Intervention: Drug: pazopanib in combination with weekly topotecan
Sponsors: Charite University, Berlin, Germany; JSehouli; GlaxoSmithKline
Not yet recruiting - verified May 2012 - Condition: Healthy
Interventions: Drug: Ticagrelor; Drug: Ticagrelor; Drug: dabigatran etexilate; Drug: dabigatran etexilate; Drug: dabigatran etexilate
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Hypercholesterolemia
Interventions: Dietary Supplement: Fabricated foods with lupin protein; Dietary Supplement: Mannitol; Dietary Supplement: Arginine; Dietary Supplement: Fabricated foods with milk protein
Sponsors: University of Jena; University of Jena; German Federal Ministry of Education and Research
Not yet recruiting - verified May 2012 - Conditions: Menopause; Healthy
Intervention: Drug: 2 mg estradiol / 1 mg norethisterone acetate (NETA)
Sponsors: Novo Nordisk; Novo Nordisk
Completed - verified May 2012 - Condition: Mild-to-moderate Psoriasis Vulgaris
Intervention: Drug: DLX105
Sponsors: Delenex Therapeutics AG; Delenex Therapeutics AG
Enrolling by invitation - verified February 2012 - Condition: Type 2 Diabetes Mellitus
Interventions: Drug: lixisenatide (AVE0010); Drug: liraglutide
Sponsors: Sanofi-Aventis; Sanofi-Aventis
Recruiting - verified May 2012 - Condition: Neuroendocrine Tumors
Intervention: Drug: RAD001
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified May 2012 - Condition: Coronary Heart Disease
Interventions: Drug: ORSIRO; Device: XIENCE PRIME DES
Sponsors: Deutsches Herzzentrum Muenchen; Deutsches Herzzentrum Muenchen
Recruiting - verified May 2012 - Condition: Intestinal Obstruction
Interventions: Drug: Loperamide placebo; Drug: Loperamide; Device: Colon Transit; Drug: Sulfasalazine; Drug: Placebo of MNTX and NLX; Drug: Naloxone; Drug: Methylnaltrexone
Sponsors: University Medicine Greifswald; University Medicine Greifswald
Completed - verified May 2012 - Condition: Intestinal Obstruction
Interventions: Drug: Loperamide; Drug: Loperamide placebo; Drug: Methylnaltrexone placebo; Drug: Methylnaltrexone 12 mg sc.; Drug: Methylnaltrexone IR capsule; Drug: Methylnaltrexone ER capsule; Device: Colon Transit; Drug: Sulfasalazine
Sponsors: University Medicine Greifswald; University Medicine Greifswald
Completed - verified May 2012 - Conditions: Ventricular Arrhythmias; Cardiac Death
Intervention:
Sponsors: Hannover Medical School; Hannover Medical School
Recruiting - verified May 2012 - Conditions: Neoplasm Metastasis; Neoplastic Processes; Neoplasm Recurrence, Local; Neoplasm, Residual; Pain
Intervention: Radiation: Radiosurgery
Sponsors: Wuerzburg University Hospital; Wuerzburg University Hospital; Royal Marsden NHS Foundation Trust
Active, not recruiting - verified May 2012 - Condition: Concussed Athletes
Intervention: Behavioral: tDCS
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany
Recruiting - verified May 2012 - Condition: Healthy
Interventions: Drug: Placebo; Drug: BI 1015550; Drug: BI 1015550; Drug: BI 1015550; Drug: BI 1015550; Drug: BI 1015550; Drug: BI 1015550; Drug: BI 1015550; Drug: BI 1015550; Drug: BI 1015550
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Not yet recruiting - verified May 2012 - Conditions: Encephalopathy, Hepatic; Cerebrovascular Disorders; Liver Failure
Intervention: Other: No interventions
Sponsors: Johannes Gutenberg University Mainz; Johannes Gutenberg University Mainz
Recruiting - verified May 2012 - Conditions: Diabetics Mellitus Type 1; Diabetes Mellitus Type 2
Intervention: Device: InsuPad
Sponsors: Insuline Medical Ltd.; Insuline Medical Ltd.
Not yet recruiting - verified May 2012 - Condition: Lactose Malabsorption
Interventions: Dietary Supplement: Acid lactase; Dietary Supplement: Acid lactase; Dietary Supplement: Lyoph. yoghurt bacteria; Dietary Supplement: Acid lactase plus yoghurt bacteria; Dietary Supplement: Placebo
Sponsors: Vitacare Gmbh & Co. KG; Vitacare Gmbh & Co. KG
Completed - verified May 2012 - Condition: Proliferative Diabetic Retinopathy (PDR)
Interventions: Drug: Ranibizumab; Procedure: Laser photocoagulation; Procedure: Ranibizumab & laser photocoagulation
Sponsors: Novartis; Novartis Pharmaceuticals; Cologne Image Reading Center & Laboratory (CIRCL); Spranger Laboratories
Not yet recruiting - verified May 2012 - Condition: Unilateral HER2 Positive Breast Cancer
Interventions: Drug: Afatinib; Drug: Trastuzumab; Drug: Paclitaxel; Drug: Epirubicin; Drug: Cyclophosphamide
Sponsors: German Breast Group; German Breast Group; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Healthy Subjects
Interventions: Device: Litramine; Device: Placebo
Sponsors: InQpharm Group; InQpharm Group
Recruiting - verified May 2012 - Conditions: Diabetes; Diabetes Mellitus, Type 1
Interventions: Drug: insulin degludec; Drug: insulin degludec/insulin aspart
Sponsors: Novo Nordisk; Novo Nordisk
Recruiting - verified May 2012 - Conditions: Gingivitis; Periodontitis
Interventions: Device: metal-free interdental brush; Device: metal-core interdental brush
Sponsors: University of Freiburg; University of Freiburg
Completed - verified May 2012 - Conditions: Smoking; Tobacco Use Cessation; Smoking Cessation
Interventions: Behavioral: Brief advice; Behavioral: Compact cessation course; Behavioral: Standard cessation course
Sponsors: University of Heidelberg; University of Heidelberg; Pfizer
Enrolling by invitation - verified April 2012 - Condition: Familial Chylomicronemia Syndrome (FCS) (HLP Type I)
Intervention: Drug: LCQ908
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified April 2012 - Condition: Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis
Interventions: Drug: CAZ-AVI; Drug: Doripenem; Drug: Either 500 mg of Ciprofloxacin (oral); Drug: or 800 mg/160 mg of sulfamethoxazole/trimethoprim (oral)
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified May 2012 - Condition: Laryngeal Injuries
Interventions: Drug: Sevoflurane; Drug: Rocuronium
Sponsors: University of Rostock; University of Rostock
Recruiting - verified May 2012 - Condition: Diabetes Mellitus Type 2
Intervention:
Sponsors: GWT-TUD GmbH; GWT-TUD GmbH; Bayer
Not yet recruiting - verified May 2012 - Condition: Healthy
Interventions: Drug: BI 163538 XX; Drug: Placebo to BI 163538 XX
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Anticoagulation Treatment
Intervention:
Sponsors: GWT-TUD GmbH; GWT-TUD GmbH
Recruiting - verified May 2012 - Condition: Healthy
Interventions: Drug: BI 187004 CL; Drug: Placebo to BI 187004 CL
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Mild to Moderate Psoriasis
Interventions: Other: TTOP; Other: non-TTOP
Sponsors: Reich, Kristian, M.D.; Kristian Reich, MD; LEO Pharma
Recruiting - verified May 2012 - Condition: Cardiovascular Disease
Interventions: Drug: N(t)RTI) + boosted protease inhibitors (PI/r); Drug: maraviroc + boosted protease inhibitors (PI/r); Drug: maraviroc + N(t)RTI)
Sponsors: Kirby Institute; Kirby Institute
Not yet recruiting - verified April 2012 - Condition: Allergic Rhinitis
Interventions: Drug: WF10; Drug: NaCl Solution
Sponsors: Nuvo Research GmbH; Nuvo Research GmbH
Completed - verified February 2010 - Condition: Rectal Cancer
Interventions: Procedure: TME; Procedure: TME; Procedure: Neuromonitoring
Sponsors: Johannes Gutenberg University Mainz; Johannes Gutenberg University Mainz
Not yet recruiting - verified April 2012 - Condition: Multiple Sclerosis
Intervention: Drug: FTY720
Sponsors: Novartis; Novartis Pharmaceuticals
Not yet recruiting - verified April 2012 - Condition: Mini-Stroke
Intervention: Behavioral: Patient centered structured support program
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany; Technische Universität München; University of Erlangen-Nürnberg Medical School; Praxis für Neurologie und Psychiatrie am Prinzregentenplatz, München; Berlin University of Technology
Recruiting - verified April 2012 - Condition: GI-bleeding
Intervention: Device: capsule endoscopy
Sponsors: Technische Universität München; Technische Universität München
Recruiting - verified April 2012 - Condition: Tuberculosis
Intervention:
Sponsors: Research Center Borstel; Research Center Borstel; German Cancer Research Center
Recruiting - verified April 2012 - Condition: Allergic Rhinitis
Interventions: Drug: Levocetirizine; Drug: Fexofenadine
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany
Completed - verified April 2012 - Conditions: Apnea; Hypoxemia; Complications
Intervention: Procedure: capnography
Sponsors: Technische Universität München; Technische Universität München
Completed - verified April 2012 - Conditions: Ischemic Stroke; Hemorrhagic Stroke
Interventions: Drug: Cold crystalloid infusions, 0.9%NaCl or Ringer's solution; Device: EMCOOLS Flex.Pads
Sponsors: University Hospital Heidelberg; University Hospital Heidelberg
Recruiting - verified April 2012 - Conditions: Ischemic Stroke; Hemorrhagic Stroke
Interventions: Drug: Cold crystalloid infusions, 0.9%NaCl or Ringer's; Device: EMCOOLS Brain.Pad
Sponsors: University Hospital Heidelberg; University Hospital Heidelberg
Recruiting - verified April 2012 - Conditions: Guillain-Barré Syndrome; Miller Fisher Syndrome
Intervention:
Sponsors: Erasmus Medical Center; Erasmus Medical Center
Recruiting - verified May 2012 - Condition: Pulmonary Vein Isolation, Ablation Time, Procedure Time, Freedom Form Atrial Fibrillation
Interventions: Procedure: Circumferential pulmonary vein ablation; Procedure: single ring pulmonary vein ablation
Sponsors: University Medical Center Goettingen; University Medical Center Goettingen; Stereotaxis
Completed - verified April 2012 - Condition: Asthma
Interventions: Drug: MEMP1972A; Drug: MEMP1972A; Drug: MEMP1972A; Drug: placebo
Sponsors: Genentech; Genentech
Not yet recruiting - verified April 2012 - Condition: Hepatitis C
Interventions: Drug: TMC647055; Drug: TMC647055; Drug: TVR; Drug: TVR; Drug: TVR; Drug: PegFN; Drug: RBV
Sponsors: Janssen R&D Ireland; Janssen Infectious Diseases Research & Development Ireland
Not yet recruiting - verified April 2012 - Condition: Healthy
Interventions: Drug: Linagliptin/metformin; Drug: Linagliptin; Drug: Metformin
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Healthy
Interventions: Drug: BI 411034; Drug: BI 411034; Drug: BI 411034; Drug: BI 411034; Drug: BI 411034; Drug: BI 411034; Drug: BI 411034; Drug: BI 411034; Drug: Placebo
Sponsors: Boehringer Ingelheim Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals
Recruiting - verified May 2012 - Condition: Opioid Related Disorder
Interventions: Drug: RBP-6300; Drug: Placebo
Sponsors: Reckitt Benckiser Pharmaceuticals, Inc; Reckitt Benckiser Pharmaceuticals, Inc
Recruiting - verified February 2012 - Condition: Actinic Keratosis
Interventions: Drug: Resiquimod; Drug: Placebo / Vehicle; Drug: Resiquimod; Drug: Resiquimod
Sponsors: Spirig Pharma Ltd.; Spirig Pharma Ltd.
Not yet recruiting - verified April 2012 - Condition: Cold Contact Urticaria
Interventions: Drug: Omalizumab; Drug: Omalizumab; Drug: Placebo
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany; Novartis Pharmaceuticals
Recruiting - verified April 2012 - Conditions: Tubular Breast Cancer Stage II; Mucinous Breast Cancer Stage II; Breast Cancer Female NOS; Invasive Ductal Breast Cancer; Tubular Breast Cancer Stage III; HER-2 Positive Breast Cancer; Inflammatory Breast Cancer Stage IV; Inflammatory Breast Cancer
Interventions: Drug: nab-Paclitaxel; Drug: Paclitaxel
Sponsors: German Breast Group; German Breast Group; Celgene GmbH; Roche Pharma AG
Not yet recruiting - verified April 2012 - Condition: Menstrual Pain
Intervention: Procedure: Self-care acupressure at three predefined points
Sponsors: Charite University, Berlin, Germany; Charite University, Berlin, Germany; Karl and Veronica Carstens Foundation
Not yet recruiting - verified April 2012 - Conditions: Cardiovascular Diseases; Coronary Artery Disease; Myocardial Ischemia; Coronary Disease; Coronary Restenosis; Heart Diseases; Coronary Stenosis; Arteriosclerosis; Arterial Occlusive Diseases; Vascular Diseases
Intervention:
Sponsors: Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.; Medical Care Center Prof. Mathey, Prof. Schofer, Ltd.; Abbott Vascular
Recruiting - verified May 2012 - Condition: Pulmonary Emphysema
Intervention: Device: EBV
Sponsors: Pulmonx, Inc.; Pulmonx International Sàrl
Not yet recruiting - verified April 2012 - Condition: Other Surgical Procedures
Intervention: Device: continuous GlucoseMonitor
Sponsors: University Hospital Heidelberg; Susanne Frankenhauser
Recruiting - verified May 2012
 |
Find Paid Clinical Trials in Germany |
Clinical Trial Locations 